K. A. Malle Pharmaceuticals Limited, a active public limited company, was established on 11 May 1982 in Mumbai, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U70101MH1982PLC027110. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.49 Cr.
Formerly known as K. A. Malle Leasing Company Limited. It upholds a compliant status. Employing 119 professional, Its leadership includes Shanu Pramod Podar (Director), Rahul Radheshyam Bhomavat (Director), Hemant Kumar Chaturvedi (Director). Past directors included Kamal Farokh Messman, Farokh Rustomji Messman, Shanu Pramod Podar. It holds ₹47.65 Cr open charges and ₹10.73 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2, Krishna Dham, L.S. Raheja Marg, Raheja Township, Malad East,, Mumbai, Maharashtra, 400097.
U70101MH1982PLC027110
027110
11 May 1982
₹5.00 Cr
₹1.49 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into K. A. Malle Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shanu Pramod Podar | Director | 28 Feb 2014 | Current |
| Rahul Radheshyam Bhomavat | Director | 08 Jun 2018 | Current |
| Hemant Kumar Chaturvedi | Director | 08 Nov 2021 | Current |
| Divyakumar Jain | Director | 08 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Feb 2008 | Past |
| Pramod Abcsdd | Director | 08 Feb 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Ceo(Kmp) | - | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Director | 06 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
K. A. Malle Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.13% decrease. The company also saw a substantial fall in profitability, with a 406.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 180.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, K. A. Malle Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹476,500,000.00
₹107,255,630.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2008 | The Cosmos Co-Operative Bank Ltd | ₹46.65 Cr | Open |
| 06 Dec 1985 | Standard Chartered Bank | ₹1.00 Cr | Open |
| 09 Apr 2013 | The Cosmos Co-Operative Bank Ltd. | ₹5.00 M | Satisfied |
| 21 Apr 2012 | The Cosmos Co-Op Bank Ltd | ₹0.70 M | Satisfied |
| 23 Jul 2011 | The Cosmos Co-Op Bank Ltd | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
K. A. Malle Pharmaceuticals has a workforce of 119 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of K. A. Malle Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K. A. Malle Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
K. A. Malle Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
K. A. Malle Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Hemant Kumar Chaturvedi was appointed as a Director was appointed as a Director on 08 Nov 2021 & has been associated with this company since 4 years 20 days . was documented.
Progress on A charge registered on 21 Apr 2012 via Charge ID 10353329 with The Cosmos Co-Op Bank Ltd was fully satisfied on 05 Jul 2019. was documented.
Progress on Divyakumar Jain was appointed as a Director was appointed as a Director on 08 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
Rahul Radheshyam Bhomavat was appointed as a Director was appointed as a Director on 08 Jun 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.
The CIN of K. A. Malle Pharmaceuticals Limited is U70101MH1982PLC027110.
K. A. Malle Pharmaceuticals Limited is headquartered at 2, Krishna Dham, L.S. Raheja Marg, Raheja Township, Malad East,, Mumbai, Maharashtra, 400097.
K. A. Malle Pharmaceuticals Limited was incorporated on 11 May 1982.
The current directors of K. A. Malle Pharmaceuticals Limited are
The primary industry of K. A. Malle Pharmaceuticals Limited is Manufacturing.
K. A. Malle Pharmaceuticals Limited is unlisted.
The authorized capital of K. A. Malle Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹1.49 Cr.
The compliance status of K. A. Malle Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX